Exploring\nthe 1‑(4-Nitrophenyl)-3-arylprop-2-en-1-one\nScaffold for the Selective Inhibition of Monoamine Oxidase B

A small library of 1-(4-nitrophenyl)-3-arylprop-2-en-1-one\nderivatives\nwas synthesized to identify new human monoamine oxidase B selective\ninhibitors. Their inhibitory activity toward MAO-A and MAO-B isoforms\nwas evaluated to determine their potency and selectivity. All newly\nsynthesized compounds were nanomolar inhibitors of the B isoform with\nIC<sub>50</sub> concentrations ranging from 120 to 2.2 nM. Conversely,\ntheir activity toward the A isozyme was only observed at micromolar\nconcentrations. Our results bear out the hypothesis that the 1,3-diarylpropenone\nscaffold could represent a valuable starting point for designing efficient\nand selective MAO-B inhibitors.

Publication Details

Journal
Figshare
Published
2024-09-27
DOI
https://doi.org/10.1021/acsmedchemlett.4c00246.s001
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring\nthe 1‑(4-Nitrophenyl)-3-arylprop-2-en-1-one\nScaffold for the Selective Inhibition of Monoamine Oxidase B

Figshare
Parkinson's Disease Mechanisms and Treatments
article

Exploring\nthe 1‑(4-Nitrophenyl)-3-arylprop-2-en-1-one\nScaffold for the Selective Inhibition of Monoamine Oxidase B

article en

Abstract

A small library of 1-(4-nitrophenyl)-3-arylprop-2-en-1-one\nderivatives\nwas synthesized to identify new human monoamine oxidase B selective\ninhibitors. Their inhibitory activity toward MAO-A and MAO-B isoforms\nwas evaluated to determine their potency and selectivity. All newly\nsynthesized compounds were nanomolar inhibitors of the B isoform with\nIC<sub>50</sub> concentrations ranging from 120 to 2.2 nM. Conversely,\ntheir activity toward the A isozyme was only observed at micromolar\nconcentrations. Our results bear out the hypothesis that the 1,3-diarylpropenone\nscaffold could represent a valuable starting point for designing efficient\nand selective MAO-B inhibitors.

Figshare
Openalex Percentile: Top 49%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Exploring\nthe 1‑(4-Nitrophenyl)-3-arylprop-2-en-1-one\nScaffold for the Selective Inhibition of Monoamine Oxidase B · Figshare (2024) | TGRS Research Map | TGRS